MedPath

Borstkanker vaststellen met een ademtest met een electronische neus

Recruiting
Conditions
breath analysis
breast cancer
diagnostic procedures
electronic nose
Registration Number
NL-OMON28999
Lead Sponsor
Alexander Monro Hospital, BilthovenMedisch Spectrum Twente, EnschedeZiekenhuis Bernhoven, Uden
Brief Summary

9. Timmer-Bonte J, Grosfeld, N. Seelen-Janssen, L. Veenendaal, F. Zijlstra. Breast cancer diagnosis and subtyping by analysing exhaled breath: A pilot study using a portable electronic nose (Aeonose®). European Journal of Cancer supl.2 (2016) #496

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
800
Inclusion Criteria

•Patients entering the hospital with suspected BC

•Patients age of 18 years and older

Exclusion Criteria

Patients with a history of proven primary BC and other malignancies,

•Patients currently treated with radio- or chemotherapy.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary parameters of diagnostic relevance will be sensitivity, specificity, positive and negative likelihood ratio, and positive and negative predicted value of the Aeonose. <br />Histopathological examination of the biopsies is considered the gold standard.
Secondary Outcome Measures
NameTimeMethod
Patients Reported Outcome measures <br /><br>Cost-effectiveness analysis (Markov model)
© Copyright 2025. All Rights Reserved by MedPath